Open Medicine (Jun 2024)

Comprehensive pan-cancer investigation of carnosine dipeptidase 1 and its prospective prognostic significance in hepatocellular carcinoma

  • Huang Xiao-Wen,
  • Li Yan,
  • Jiang Li-Na,
  • Zhao Bo-Kang,
  • Liu Yi-Si,
  • Chen Chun,
  • Zhao Dan,
  • Zhang Xue-Li,
  • Li Mei-Ling,
  • Jiang Yi-Yun,
  • Liu Shu-Hong,
  • Zhu Li,
  • Zhao Jing-Min

DOI
https://doi.org/10.1515/med-2024-0982
Journal volume & issue
Vol. 19, no. 1
pp. 745 – 58

Abstract

Read online

Carnosine dipeptidase 1 (CNDP1), an enzyme integral to the hydrolysis of dipeptides containing histidine, plays an indispensable role in myriad physiological processes, including hydrolysis of proteins, maturation of specific biochemical functionalities within proteins, tissue regeneration, and regulation of cell cycle. However, the implications of CNDP1 in oncogenesis and its prognostic value are not yet fully elucidated. Initially, we procured the GSE40367 dataset from the Gene Expression Omnibus and established a protein–protein interaction network. Thereafter, we conducted functional and pathway enrichment analyses utilizing GO, KEGG, and GSEA. Moreover, we undertook an association analysis concerning the expression of CNDP1 with immune infiltration, along with survival analysis across various cancers and specifically in hepatocellular carcinoma (HCC). Our study uncovered a total of 2,248 differentially expressed genes, with a down-regulation of CNDP1 in HCC and other cancers. Our explorations into the relationship between CNDP1 and immune infiltration disclosed a negative correlation between CNDP1 expression and the presence of immune cells in HCC. Survival analyses revealed that diminished expression of CNDP1 correlates with an adverse prognosis in HCC and several other types of cancer. These observations intimate that CNDP1 holds promise as a novel prognostic biomarker for both pan-cancer and HCC.

Keywords